Koo, based on the May 5, 2021 $6 million USD debenture press release Hepa holds 35.72% of the RVX shares and if  they convert their existing warrants they will hold 38.67%. If they convert the $6,000,000 USD (approx $7,560,000) at the $.93 as per the debenture they could add approx 8,129,032 shares of approx 3.3%. So hypothetically they could own roughly 41.97 with ORI Capital at 6.7% for a total of 48%+.

Anyway I'm just playing around with hypothetical nonsense in the typical RVX mushroom management game we are in.

Bottom line is we need an update on the Covid trial and funding/partnership for BoM2. It would also be wonderful to hear about funding and action on the many other golden opportunities such as HIV, PAH, Fabry, etc. Come September it will be 2 years since the top line BoM results were announced.

Then we need a concrete presentation on value creation for shareholders. Then guys like me will shut up.

Enjoy the rest of the summer folks  :)

Toinv